Founded in 1995 by Wayne Phillips and acquired by McCann Health in 2012, Double Helix is a well established and rapidly growing pharmaceutical market access consultancy dedicated to the Life Sciences sector, providing pharmaceutical, biotech and medical device clients of all sizes with the knowledge to evolve their brands and businesses. Wayne is a physician with over 30 years' experience in the pharmaceutical industry, of which 16 years was in clinical development and medical marketing. After spending several years working for the pharmaceutical industry where he gained expertise in clinical development, biostatistics, regulatory affairs and medical communications, Wayne's background enabled him to found Double Helix with a vision to create a global healthcare consultancy
As experienced practitioners of innovative, robust and actionable solutions in tactical and strategic market research, market access, pricing and reimbursement, HEOR and Medical Devices, Biotechnologies & Diagnostics, Double Helix's services are global in reach - spanning all key markets worldwide, as well as covering local UK and US domestic market needs.
About McCann Health: Comprising the world's most connected health and wellness experts, McCann Health is the most awarded professional and consumer health communications network with the largest international expertise spanning 35 countries and 61 offices. McCann Health's global network includes Double Helix, McCann HumanCare, McCann Healthcare, McCann Regan Campbell Ward, McCann Torre Lazur-- as well as the leading worldwide medical communications and consultancy practice, McCann Complete Medical. McCann Health is a part of McCann Worldgroup, the largest marketing communications agency network in the world, and is a leading healthcare agency network owned by Interpublic Group [NYSE: IPG].
Double Helix Consulting launches a new series of payer brunch advisory boards Thursday June 20th. Pose your questions and join the discussion on Twitter (@DoubleHelixMA) by using the hashtag #DHCBrunch.